TruBridge (TBRG) Q3 2025 earnings review
Profits Accelerate, But Collapsing Bookings Signal Top-Line Trouble
TruBridge executed a textbook financial turnaround this quarter, reversing a year-ago loss into a $5.6M Net Income profit and slashing net leverage to 2.2x. However, the future growth pipeline is flashing red. Q3 Bookings plummeted 26% YoY and 39% sequentially to $15.5M—missing internal targets by 20%. Management blames delayed hospital decisions and a pivot to higher-margin contracts, but rising client churn in the core billing business indicates deeper competitive issues. The company is successfully squeezing more profit out of a stagnant revenue base, but the top-line engine is decelerating.
🐂 Bull Case
Adjusted EBITDA margin expanded from 17.3% to 18.9% YoY. Management's aggressive cost optimization and the restart of the India offshore transition are yielding tangible bottom-line results, with another 200 bps of margin expansion targeted for 2026.
Free Cash Flow more than doubled YTD to $14.8M. The company paid down ~$35M in debt since January 2024, cutting the net leverage ratio in half (from 4.4x to 2.2x).
🐻 Bear Case
Q3 Bookings of $15.5M were explicitly labeled 'underwhelming' by management. The 39% sequential drop highlights severe execution risk and a lack of revenue visibility heading into 2026.
Despite narrative claims that Financial Health is the growth engine, the segment's Adjusted EBITDA fell 11% YoY ($10.0M to $8.9M). Client retention in the Central Business Office (CBO) remains a persistent leak.
⚖️ Verdict: ⚪
Neutral. The financial cleanup and deleveraging are highly commendable, but you cannot shrink your way to long-term growth. Until bookings stabilize and CBO churn is fixed, the stock's upside is capped by top-line stagnation.
Key Themes
Narrative Contradiction: Financial Health Margins Are Reversing
Management continuously points to Financial Health as the company's primary growth engine, but the data tells a contradicting story. Financial Health Adjusted EBITDA actually dropped 11% YoY (from $10.0M to $8.9M). The entire corporate profitability improvement was carried by the legacy Patient Care segment, whose EBITDA surged 56%. This is a major red flag indicating that the cost of servicing CBO clients or replacing churned revenue is eating into the segment's profitability.
Bookings Trajectory Decelerating Rapidly
Q3 TCV bookings of $15.5M missed internal expectations by 20%. Management attempted to spin this as a strategic shift toward 'higher-quality' deals (like the 70-80% margin Encoder business) and larger 100-400 bed hospital contracts. However, a 39% sequential drop reveals high deal lumpiness and poor pipeline conversion. If Q4 doesn't show a massive rebound, 2026 revenue growth is mathematically compromised.
Offshore Transition and Cost Cuts Accelerating Margins
The operational transformation is working. Following a Q2 pause, the offshore transition to India officially restarted on October 1 at a 'measured pace.' Management expects this initiative, combined with a 30% YTD reduction in capitalized software spend, to drive an additional ~200 bps of EBITDA margin expansion in 2026.
Patient Care Margins Accelerating
The legacy Patient Care segment is punching above its weight. Gross margins expanded by an impressive 370 bps to ~60%. By sunsetting underperforming products (Centriq) and shifting to higher-margin non-recurring implementation/consulting revenues alongside steady SaaS streams, this segment is currently the company's strongest profit pillar.
Macro Hospital Budgets Delaying Decisions
The macro picture remains a headwind. Management cited uncertainty surrounding calendar-year hospital budgets and regulatory impacts (like the rural hospital fund) as primary reasons for delayed customer signatures. While they expect this to alleviate as 2026 budgets finalize, TruBridge's target market (community hospitals) remains highly sensitive to federal policy shifts.
CBO Client Retention Remains Unstable
Despite implementing a multi-quarter remediation plan earlier in the year, absolute client losses in the core Central Business Office (CBO) actually 'increased a little in Q3.' Management admits this is a work in progress. If they cannot fix service quality, the cost of acquiring new customers simply to replace churn will severely constrain free cash flow.
Other KPIs
Reversing. A massive improvement from the -$9.1 million loss in 24Q3. The company is firmly back in GAAP profitability, proving that the restructuring and debt paydown over the last 18 months have structurally fixed the bottom line.
Accelerating. More than double the $6.9 million generated in the same period last year. This cash conversion was driven by a reduction in CapEx (software development) from $14.9M to $13.3M and fundamentally stronger operating cash generation.
Decelerating. Debt load continues to step down predictably quarter after quarter. Management noted a total paydown of ~$35M since January 2024, significantly reducing interest expense drag (down 25% YoY to $3.0M in Q3).
Guidance
Stable. The range was narrowed slightly from the prior $345 - $350 million. The midpoint ($346.5M) implies a meager 1.1% YoY growth vs FY24's $342.6M. Top-line growth has effectively stalled.
Accelerating. The bottom end of the range was raised from $62.0 million. The midpoint ($66.5M) implies a robust 17.5% YoY growth over FY24's $56.6M, underscoring the success of the margin expansion initiatives.
Accelerating. The midpoint of $18.0M represents an acceleration both sequentially (vs $16.3M in Q3) and places Q4 margin at roughly 20%, achieving management's exit-rate target.
Key Questions
Financial Health Margin Disconnect
If Financial Health is the future growth engine and the focus of high-margin Encoder sales, why did the segment's Adjusted EBITDA fall 11% year-over-year while the legacy Patient Care segment grew profits by 56%?
Bookings Conversion Reality
You missed Q3 internal bookings targets by 20% due to 'delayed decisions'. What percentage of these specific delayed deals have already been signed in October, versus deals that are still sitting in pipeline limbo?
CBO Churn Baseline
You mentioned absolute client losses in CBO increased in Q3. What is the current net revenue retention rate specifically for the CBO cohort, and when mathematically will the offshore cost savings outpace the revenue lost to churn?